Participatory Research for Suicide Prevention in Autism
Launched by UNIVERSITY OF UTAH · Aug 9, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Participatory Research for Suicide Prevention in Autism," is testing a new educational program aimed at helping people who work with autistic individuals learn more about preventing suicide. The study wants to find out if this program can improve participants’ knowledge and skills to support autistic people better. Additionally, researchers are interested in hearing participants' feedback to make the program even better.
To take part in this study, you need to be an active member of an organization that helps autistic people and be at least 18 years old. Participants will engage in a four-part online training course and complete surveys before, after, and three months later to share what they've learned. There's also an option to join an interview for more detailed feedback. This study is currently looking for participants of all genders, so if you meet the criteria and are interested, it could be a great opportunity to make a difference in suicide prevention for autistic individuals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Active member of an organization whose work impacts autistic people
- • Age 18+
- • Fluent English language to participate in virtual educational intervention
- Exclusion Criteria:
- • No access to an internet-connected device
- • Unable to participate in a virtual educational intervention
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Anne V Kirby, PhD
Principal Investigator
University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported